What is the share price of Global Health Ltd (MEDANTA) today?
The share price of MEDANTA as on 5th December 2025 is ₹1174. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Global Health Ltd (MEDANTA) share?
The past returns of Global Health Ltd (MEDANTA) share are- Past 1 week: -4.31%
- Past 1 month: -5.18%
- Past 3 months: -15.48%
- Past 6 months: 0.33%
- Past 1 year: 3.30%
- Past 3 years: 162.50%
- Past 5 years: 189.14%
What are the peers or stocks similar to Global Health Ltd (MEDANTA)?
The peers or stocks similar to Global Health Ltd (MEDANTA) include:What is the market cap of Global Health Ltd (MEDANTA) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Global Health Ltd (MEDANTA) is ₹32257.98 Cr as of 5th December 2025.What is the 52 week high and low of Global Health Ltd (MEDANTA) share?
The 52-week high of Global Health Ltd (MEDANTA) is ₹1456.50 and the 52-week low is ₹996.45.What is the PE and PB ratio of Global Health Ltd (MEDANTA) stock?
The P/E (price-to-earnings) ratio of Global Health Ltd (MEDANTA) is 67.00. The P/B (price-to-book) ratio is 9.52.Which sector does Global Health Ltd (MEDANTA) belong to?
Global Health Ltd (MEDANTA) belongs to the Health Care sector & Hospitals & Diagnostic Centres sub-sector.How to buy Global Health Ltd (MEDANTA) shares?
You can directly buy Global Health Ltd (MEDANTA) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Global Health Ltd
MEDANTA Share Price
1,174.002.23% (-26.80)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
MEDANTA Stock Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
AvgFinancials growth has been moderate for a few years
Profitability
HighShowing good signs of profitability & efficiency
Entry point
GoodThe stock is underpriced and is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
MEDANTA Performance & Key Metrics
MEDANTA Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 57.43 | 9.52 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 36.94 | 5.83 | 0.58% |
64%
Analysts have suggested that investors can buy this stock
from 14 analysts
Price Upside
Earnings Growth
Rev. Growth
MEDANTA Company Profile
Global Health Limited, formerly Global Health Private Limited, is an India-based company. The Company is a tertiary care provider operating in the North and East regions of India. The Company operates approximately four hospitals under Medanta brand
MAXHEALTH
PE Ratio
98.00
98.00
1Y Return
1.85%
1.85%
Buy Reco %
77.27
77.27
APOLLOHOSP
PE Ratio
71.61
71.61
1Y Return
0.43%
0.43%
Buy Reco %
86.21
86.21
FORTIS
PE Ratio
86.64
86.64
1Y Return
24.99%
24.99%
Buy Reco %
75.00
75.00
PE Ratio
49.80
49.80
1Y Return
47.18%
47.18%
Buy Reco %
77.78
77.78
ASTERDM
PE Ratio
6.28
6.28
1Y Return
34.87%
34.87%
Buy Reco %
100.00
100.00
MEDANTA Sentiment Analysis
MEDANTA Sentiment Analysis
New
Crisp summary & key insights to decode earnings calls instantly
MEDANTA Stock Summary · November 2025
Medanta's recent operational developments reflect a strategic commitment to enhancing healthcare delivery while navigating the complexities of the market. The Noida hospital, which began operations in September 2025, has generated initial revenue but faces challenges in achieving immediate profitability due to ramp-up costs. Despite these hurdles, management remains optimistic about future growth, bolstered by a strong community response and plans for further expansion, including a new super specialty hospital in Guwahati. The company is also addressing insurance and payment challenges, particularly in the CGHS segment, while maintaining a robust financial position with a net cash surplus. Overall, Medanta's focus on clinical talent, advanced technologies, and operational efficiencies positions it well for sustainable growth in a competitive landscape.
MEDANTA Stock Growth Drivers
MEDANTA Stock Growth Drivers
7Expansion of Healthcare Facilities
The company has successfully commenced operations at its sixth hospital, Medanta Noida, which began in
Strong Financial Performance
In Q2 FY26, the company reported a consolidated total income of INR 11,189 million, reflecting
MEDANTA Stock Challenges
MEDANTA Stock Challenges
3Tapering Growth in Average Revenue Per Occupied Bed (ARPOB)
The growth in Average Revenue Per Occupied Bed (ARPOB) is currently tapering, with increases now
Challenges in CGHS Operations
Despite recent price increases in the Central Government Health Scheme (CGHS) business, the actual impact
MEDANTA Forecast
MEDANTA Forecasts
Price
Revenue
Earnings
MEDANTA Share Price Forecast
MEDANTA Share Price Forecast
2025
Current
₹1,200.80
Baseline
Forecast for Dec 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹
2025
Current
₹1,200.80
Baseline
Forecast for Dec 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹
MEDANTA Company Revenue Forecast
MEDANTA Company Revenue Forecast
2025
Current
₹3.77
Baseline
Forecast for Mar 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹ Thousand cr.
2025
Current
₹3.77
Baseline
Forecast for Mar 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹ Thousand cr.
MEDANTA Stock EPS (Earnings Per Share) Forecast
MEDANTA Stock EPS (Earnings Per Share) Forecast
2025
Current
₹17.93
Baseline
Forecast for Mar 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹
2025
Current
₹17.93
Baseline
Forecast for Mar 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹
MEDANTA
MEDANTA
Income
Balance Sheet
Cash Flow
Annual Normal View
MEDANTA Income Statement
MEDANTA Income Statement
Annual Normal View
| Financial Year | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 1,392.17 | 1,505.99 | 1,544.27 | 1,478.16 | 2,205.82 | 2,759.17 | 3,349.77 | 3,771.42 | 4,083.88 | |||||||||
Raw Materials | 313.43 | 324.92 | 324.83 | 353.60 | 545.75 | 626.86 | 761.65 | 882.42 | 3,098.69 | |||||||||
| Power & Fuel Cost | 29.55 | 30.65 | 34.60 | 38.56 | 47.06 | 57.12 | 59.91 | 62.12 | ||||||||||
| Employee Cost | 526.64 | 541.08 | 538.78 | 466.34 | 567.96 | 635.65 | 734.86 | 824.54 | ||||||||||
| Selling & Administrative Expenses | 211.20 | 324.96 | 365.77 | 298.10 | 444.56 | 623.16 | 759.27 | 881.51 | ||||||||||
| Operating & Other expenses | 137.01 | 61.90 | 44.83 | 93.23 | 103.90 | 130.83 | 150.48 | 205.47 | ||||||||||
EBITDA | 174.34 | 222.48 | 235.46 | 228.33 | 496.59 | 685.55 | 883.60 | 915.36 | 985.19 | |||||||||
| Depreciation/Amortization | 86.36 | 101.60 | 115.04 | 123.21 | 129.71 | 149.92 | 172.73 | 193.75 | 192.54 | |||||||||
| PBIT | 87.98 | 120.88 | 120.42 | 105.12 | 366.88 | 535.63 | 710.87 | 721.61 | 792.65 | |||||||||
| Interest & Other Items | 28.29 | 37.64 | 56.56 | 72.64 | 86.32 | 86.33 | 83.78 | 74.35 | 62.21 | |||||||||
| PBT | 59.69 | 83.24 | 63.86 | 32.48 | 280.56 | 449.30 | 627.09 | 647.26 | 730.44 | |||||||||
| Taxes & Other Items | 26.81 | 31.94 | 27.54 | 3.66 | 84.36 | 123.21 | 148.91 | 165.82 | 168.70 | |||||||||
| Net Income | 32.88 | 51.30 | 36.32 | 28.82 | 196.20 | 326.09 | 478.18 | 481.44 | 561.74 | |||||||||
| EPS | 1.36 | 2.10 | 1.48 | 1.17 | 7.83 | 12.51 | 17.82 | 17.93 | 20.92 | |||||||||
| DPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.50 | |||||||||
| Payout ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.02 |
MEDANTA Company Updates
FY 2026FY 2026
Investor Presentation
Nov 7PDF
MEDANTA Stock Peers
MEDANTA Past Performance & Peer Comparison
MEDANTA Past Performance & Peer Comparison
Comparing 3 stocks from
Health CareHospitals & Diagnostic Centres
Compare valuation on Screener
Health CareHospitals & Diagnostic Centres
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Global Health Ltd | 67.00 | 9.52 | — |
| Max Healthcare Institute Ltd | 98.00 | 11.24 | 0.14% |
| Apollo Hospitals Enterprise Ltd | 71.61 | 9.33 | 0.18% |
| Fortis Healthcare Ltd | 86.64 | 7.32 | 0.11% |
MEDANTA Stock Price Comparison
Compare MEDANTA with any stock or ETFCompare MEDANTA with any stock or ETF
MEDANTA
MEDANTA Holdings
MEDANTA Shareholdings
MEDANTA Promoter Holdings Trend
MEDANTA Promoter Holdings Trend
Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better
Pledged promoter holdings is insignificant
MEDANTA Institutional Holdings Trend
MEDANTA Institutional Holdings Trend
Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock
In last 3 months, foreign institutional holding of the company has almost stayed constant
MEDANTA Shareholding Pattern
MEDANTA Shareholding Pattern
MEDANTA Shareholding History
MEDANTA Shareholding History
Foreign Institutions
Mutual Funds Invested in MEDANTA
Mutual Funds Invested in MEDANTA
No mutual funds holding trends are available
Top 5 Mutual Funds holding Global Health Ltd
| Funds (Top 5) | The rupee value of the stock held by the fund divided by the stock’s market cap Market-cap held | Percentage of the fund’s portfolio invested in the stock Weight | Change in the portfolio weight of the stock over the last 3 months 3M holding change | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months Portfolio rank(3M change) |
|---|---|---|---|---|
The rupee value of the stock held by the fund divided by the stock’s market cap 0.2255% | Percentage of the fund’s portfolio invested in the stock 1.91% | Change in the portfolio weight of the stock over the last 3 months -0.23% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 17/64 (-3) | |
The rupee value of the stock held by the fund divided by the stock’s market cap 0.1874% | Percentage of the fund’s portfolio invested in the stock 1.39% | Change in the portfolio weight of the stock over the last 3 months -0.17% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 23/66 (-5) | |
The rupee value of the stock held by the fund divided by the stock’s market cap 0.1547% | Percentage of the fund’s portfolio invested in the stock 2.83% | Change in the portfolio weight of the stock over the last 3 months -0.28% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 8/64 (+1) |
Compare 3-month MF holding change on Screener
Hmm, looks like there hasn't been any net deal activity in the last 6 monthssmallcases containing MEDANTA stock
smallcases containing MEDANTA stock
Looks like this stock is not in any smallcase yet.
MEDANTA Events
MEDANTA Events
MEDANTA Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
MEDANTA has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
MEDANTA Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
MEDANTA has not given any dividends in last 5 years
MEDANTA Upcoming Dividends
MEDANTA Upcoming Dividends
No upcoming dividends are available
MEDANTA Past Dividends
MEDANTA Past Dividends
Cash Dividend
Ex DateEx DateAug 22, 2025
Final
Final | Div/Share: ₹0.50
Dividend/Share
₹0.50
Ex DateEx Date
Aug 22, 2025
MEDANTA Stock News & Opinions
MEDANTA Stock News & Opinions
Articles & Videos
Earnings
Global Health consolidated net profit rises 21.09% in the September 2025 quarter
Net profit of Global Health rose 21.09% to Rs 158.44 crore in the quarter ended September 2025 as against Rs 130.84 crore during the previous quarter ended September 2024. Sales rose 14.91% to Rs 1099.22 crore in the quarter ended September 2025 as against Rs 956.56 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales1099.22956.56 15 OPM %22.4623.86 - PBDT249.54230.53 8 PBT199.81181.10 10 NP158.44130.84 21 Powered by Capital Market - Live
3 weeks agoCapital Market - Live
Corporate
Global Health announces board meeting date
Global Health will hold a meeting of the Board of Directors of the Company on 7 November 2025.Powered by Capital Market - Live
1 month agoCapital Market - Live
Corporate
Global Health AGM scheduled
Global Health announced that the 21th Annual General Meeting(AGM) of the company will be held on 19 September 2025.Powered by Capital Market - Live
3 months agoCapital Market - Live
Earnings
Global Health consolidated net profit rises 49.60% in the June 2025 quarter
Net profit of Global Health rose 49.60% to Rs 159.01 crore in the quarter ended June 2025 as against Rs 106.29 crore during the previous quarter ended June 2024. Sales rose 19.71% to Rs 1030.84 crore in the quarter ended June 2025 as against Rs 861.08 crore during the previous quarter ended June 2024. ParticularsQuarter EndedJun. 2025Jun. 2024% Var. Sales1030.84861.08 20 OPM %23.9221.64 - PBDT253.25190.27 33 PBT208.14143.65 45 NP159.01106.29 50 Powered by Capital Market - Live
3 months agoCapital Market - Live
Earnings
Global Health standalone net profit rises 57.83% in the June 2025 quarter
Net profit of Global Health rose 57.83% to Rs 151.96 crore in the quarter ended June 2025 as against Rs 96.28 crore during the previous quarter ended June 2024. Sales rose 44.27% to Rs 882.16 crore in the quarter ended June 2025 as against Rs 611.45 crore during the previous quarter ended June 2024. ParticularsQuarter EndedJun. 2025Jun. 2024% Var. Sales882.16611.45 44 OPM %22.0621.64 - PBDT212.07153.04 39 PBT178.66129.74 38 NP151.9696.28 58 Powered by Capital Market - Live
3 months agoCapital Market - Live
Corporate
Global Health to table results
Global Health will hold a meeting of the Board of Directors of the Company on 7 August 2025.Powered by Capital Market - Live
4 months agoCapital Market - Live
Spotlight
Volumes jump at Global Health Ltd counter
PCBL Chemical Ltd, Elgi Equipments Ltd, Syrma SGS Technology Ltd, Sammaan Capital Ltd are among the other stocks to see a surge in volumes on NSE today, 09 July 2025.Global Health Ltd saw volume of 48.81 lakh shares by 14:14 IST on NSE, a 19.84 fold spurt over two-week average daily volume of 2.46 lakh shares. The stock increased 5.20% to Rs.1,281.40. Volumes stood at 2.93 lakh shares in the last session.PCBL Chemical Ltd notched up volume of 94.32 lakh shares by 14:14 IST on NSE, a 10.31 fold spurt over two-week average daily volume of 9.15 lakh shares. The stock rose 5.43% to Rs.426.30. Volumes stood at 6.51 lakh shares in the last session.Elgi Equipments Ltd recorded volume of 58.32 lakh shares by 14:14 IST on NSE, a 9.2 times surge over two-week average daily volume of 6.34 lakh shares. The stock gained 4.01% to Rs.555.50. Volumes stood at 32.93 lakh shares in the last session.Syrma SGS Technology Ltd notched up volume of 112.43 lakh shares by 14:14 IST on NSE, a 6.76 fold spurt over two-week average daily volume of 16.64 lakh shares. The stock rose 4.32% to Rs.641.75. Volumes stood at 5.31 lakh shares in the last session.Sammaan Capital Ltd saw volume of 627.72 lakh shares by 14:14 IST on NSE, a 5.35 fold spurt over two-week average daily volume of 117.29 lakh shares. The stock increased 2.13% to Rs.127.75. Volumes stood at 124.1 lakh shares in the last session.Powered by Capital Market - Live
4 months agoCapital Market - Live
Corporate
Global Health allots 1.10 lakh equity shares under ESOP
Global Health has allotted 20,000 equity shares under ESOP and 90,000 equity shares under to GHL Employees Welfare Trust ('ESOP Trust') under Part -B of GHL LTIP 2024 Plan i.e. GHL Employees Stock Purchase Scheme, 2024. Post aforesaid allotments, the paid-up share capital of the Company has increased from Rs 53,73,20,764/- divided into 26,86,60,382 equity shares of Rs. 2 each to Rs. 53,75,40,764/- divided into 26,87,70,382 equity shares of Rs. 2/- each.Powered by Capital Market - Live
5 months agoCapital Market - Live
Earnings
Global Health consolidated net profit declines 20.40% in the March 2025 quarter
Net profit of Global Health declined 20.40% to Rs 101.40 crore in the quarter ended March 2025 as against Rs 127.38 crore during the previous quarter ended March 2024. Sales rose 15.16% to Rs 931.25 crore in the quarter ended March 2025 as against Rs 808.63 crore during the previous quarter ended March 2024. For the full year,net profit rose 0.68% to Rs 481.44 crore in the year ended March 2025 as against Rs 478.19 crore during the previous year ended March 2024. Sales rose 12.74% to Rs 3692.32 crore in the year ended March 2025 as against Rs 3275.11 crore during the previous year ended March 2024. ParticularsQuarter EndedYear EndedMar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var. Sales931.25808.63 15 3692.323275.11 13 OPM %24.1322.18 -23.7524.40 - PBDT232.59188.54 23 890.91799.83 11 PBT183.34143.09 28 697.16627.10 11 NP101.40127.38 -20 481.44478.19 1 Powered by Capital Market - Live
6 months agoCapital Market - Live
Corporate
Board of Global Health recommends final dividend
Global Health announced that the Board of Directors of the Company at its meeting held on 15 May 2025, inter alia, have recommended the final dividend of Rs 0.5 per equity Share (i.e. 25%) , subject to the approval of the shareholders.Powered by Capital Market - Live
6 months agoCapital Market - Live
Over the last 5 years, revenue has grown at a yearly rate of 19.55%, vs industry avg of 13.4%
Over the last 5 years, market share increased from 3.71% to 4.73%
Over the last 5 years, net income has grown at a yearly rate of 67.68%, vs industry avg of 42.46%